Study group of adults with scleroderma for ongoing care research
Treatments studied
Part of Skin clinical trials.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must have systemic scleroderma confirmed by standard criteria, or “very early” disease with symptoms (Raynaud’s) plus specific positive blood tests
- You must be covered by a social security plan (or otherwise eligible for it)
- You must sign informed consent before any study-related review
- You must not be pregnant or breastfeeding
- You must not be under legal protection (like guardianship)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with systemic sclerosis who are being seen at a specific hospital and asks for consent to store blood and other samples for future research. It may help researchers better understand the disease and develop better tests or treatments over time.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
This study builds a registry of people with scleroderma and may store medical information and samples for future research. It can help researchers better understand the disease and develop better treatments.
This study looks at what influences people with scleroderma to join clinical trials. By taking part, you help researchers understand how to make future studies more accessible and patient-friendly.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
Hear when a new Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.